Refine
Year of publication
Document Type
- Article (779)
- Preprint (723)
- Conference Proceeding (6)
- Working Paper (5)
- Report (3)
- Doctoral Thesis (1)
Has Fulltext
- yes (1517)
Is part of the Bibliography
- no (1517)
Keywords
- Heavy Ion Experiments (21)
- Hadron-Hadron Scattering (14)
- Hadron-Hadron scattering (experiments) (11)
- LHC (10)
- Heavy-ion collision (6)
- Jets (6)
- immunotherapy (6)
- COVID-19 (5)
- ALICE experiment (4)
- Breast cancer (4)
- Collective Flow (4)
- Diagnostic markers (4)
- Heavy Ions (4)
- Heavy Quark Production (4)
- Quark-Gluon Plasma (4)
- cancer (4)
- child (4)
- children (4)
- lung cancer (4)
- ALICE (3)
- Bipolar disorder (3)
- Jets and Jet Substructure (3)
- Psychiatric disorders (3)
- biomarker (3)
- hematopoietic stem cell transplantation (3)
- pp collisions (3)
- radical prostatectomy (3)
- 140Ce (2)
- ADHD (2)
- Aspergillus fumigatus (2)
- Atrial fibrillation (2)
- Beauty production (2)
- COVID-19 surveillance (2)
- Cancer (2)
- Charm physics (2)
- Depression (2)
- Diagnostik (2)
- Drug therapy (2)
- Experimental nuclear physics (2)
- Experimental particle physics (2)
- Früherkennung (2)
- Genetics (2)
- Heart failure (2)
- Heavy-ion collisions (2)
- Hypertension (2)
- Immunology (2)
- Lepton-Nucleon Scattering (experiments) (2)
- Mammakarzinom (2)
- NIRS (2)
- Nachsorge (2)
- Nuclear reactions (2)
- Omicron (2)
- Oncology (2)
- Outcome (2)
- Particle Correlations and Fluctuations (2)
- Particle and resonance production (2)
- Particle correlations and fluctuations (2)
- Pb–Pb collisions (2)
- QCD (2)
- Quark Gluon Plasma (2)
- Quarkonium (2)
- Rehabilitation (2)
- Richtlinie (2)
- SARS-CoV-2 monitoring (2)
- Shell model (2)
- Single electrons (2)
- Structural plasticity (2)
- Suicide (2)
- Superficial vein thrombosis (2)
- Surgery (2)
- Treatment (2)
- Ursus arctos (2)
- bipolar disorder (2)
- breast cancer (2)
- data science (2)
- diagnosis (2)
- follow‑up (2)
- functional outcome (2)
- guideline (2)
- inflammation (2)
- invasive fungal disease (2)
- leukemia (2)
- outcome (2)
- prostate cancer (2)
- psoriasis (2)
- screening (2)
- 16 segment AHA model (1)
- 19F (1)
- 900 GeV (1)
- ACL (1)
- AIS (1)
- AKI (1)
- AKT (1)
- ALICE detector (1)
- ARDS (1)
- Actin (1)
- Active middle ear implants (1)
- Acute coronary syndrome (1)
- Acute inflammation (1)
- Adjustment of dosage at steady state (1)
- Adult neurogenesis (1)
- Adverse events (1)
- Age groups (1)
- Amino acid analysis (1)
- Analysis and statistical methods (1)
- Anlegerschutz (1)
- Annual General Meeting (1)
- Annual general meeting (1)
- Anti-nuclei (1)
- Anti-seizure medication (1)
- Antibody isotypes (1)
- Antifungal agents (1)
- Antigen-presenting cells (1)
- Antirheumatic agents (1)
- Aortic valve (1)
- Aortic valve replacement (1)
- Apes (1)
- Artesunate (1)
- Artificial Intelligence (1)
- Artificial intelligence (1)
- Aspergillosis (1)
- Aspergillus (1)
- Atomic and Molecular Physics (1)
- Auditory system (1)
- Autorschaft (1)
- Awareness campaign (1)
- B cell receptor (1)
- B.1.1.529 (1)
- BA.4 (1)
- BA.5 (1)
- BFIS (1)
- BI1361849 (1)
- Bacteria (1)
- Bankberatung (1)
- Behavior (1)
- Biliary tree (1)
- Biodiversity (1)
- Biodiversity Data (1)
- Biological (1)
- Biological heart valves (1)
- Biomarker (1)
- Biomarkers (1)
- Biomonitoring (1)
- Bioprosthesis (1)
- Blood pressure (1)
- Body mass index (1)
- Bone conduction devices (1)
- Bone metastases (1)
- Bone metastasis (1)
- Bone strength assessment (1)
- Boosted Jets (1)
- Botanical Collections (1)
- Brain DNA methylation (1)
- Brain injury (1)
- Breast neoplasms (1)
- Breast tumors (1)
- Business strategy in drug development (1)
- CD3/19 depletion (1)
- CD34 selection (1)
- CD36 (1)
- CEO Speeches (1)
- CEO speeches (1)
- CHRNA10 (1)
- CHRNA7 (1)
- CHRNA9 (1)
- CIK cells (1)
- COMT (1)
- COVID 19 (1)
- CRPC (1)
- CT pulmonary angiography (1)
- CT radiation exposure (1)
- CTLA-4 (1)
- CV9202 (1)
- CVID (1)
- CWS Studiengruppe (1)
- Calcium (1)
- Calorimeters (1)
- Cancer check up (1)
- Cancer detection (1)
- Cancer detection and diagnosis (1)
- Candida spp (1)
- Cardiac implantable electronic devices (1)
- Cardiac rehabilitation (1)
- Cardiac resynchronization therapy (1)
- Cardiac surgery (1)
- Cardiac troponin (1)
- Cardiovascular biology (1)
- Cardiovascular disease risk (1)
- Cardiovascular diseases (1)
- Cardiovascular magnetic resonance (1)
- Catheter ablation (1)
- Cell binding (1)
- Cell membranes (1)
- Cell staining (1)
- Cellular imaging (1)
- Centrality Class (1)
- Centrality Selection (1)
- Charged-particle density (1)
- Cherenkov counter: lead-glass (1)
- Child (1)
- Child abuse (1)
- Children (1)
- Chronic obstructive pulmonary disease (1)
- Circadian (1)
- Clinical Trials and Observations (1)
- Clinical genetics (1)
- Clinical study (1)
- Clinical trial (1)
- Clinical variation (1)
- Closure (1)
- Cohort studies (1)
- Coincidence measurement (1)
- Collective Flow, (1)
- Combo® DTS (1)
- Community ecology (1)
- Comparative effectiveness research (1)
- Comparison with QCD (1)
- Complexity (1)
- Computational models (1)
- Computational science (1)
- Computed tomography pulmonary angiography (CTPA) (1)
- Computer-aided drug design (1)
- Congenital anomalies (1)
- Consensus (1)
- Consensus document (1)
- Consensus statement (1)
- Conservation (1)
- Conservation biology (1)
- Critical care (1)
- Cryoballoon (1)
- Cryoelectron microscopy (1)
- Cryoelectron tomography (1)
- DNA sequence analysis (1)
- DNA-PAINT (1)
- DYT1 (1)
- Data processing methods (1)
- Death rates (1)
- Dendritic spines (1)
- Denosumab (1)
- Dermatomyositis (1)
- Detection workflow (1)
- Developmental programming (1)
- Diagnosis (1)
- Digital breast tomosynthesis (DBT) (1)
- Digital mammography (1)
- Digitization (1)
- Dilated cardiomyopathy (1)
- Diphosphonates (1)
- Direct reactions (1)
- Dopamine (1)
- Drug screens (1)
- Dynamical systems (1)
- Early (prenatal and postnatal) life experiences (1)
- Ecological networks (1)
- Ecology (1)
- Ecosystem ecology (1)
- Ejection fraction (1)
- Elderly (1)
- Electromagnetic transitions (1)
- Electron-pion identification (1)
- Electroweak interaction (1)
- Elliptic flow (1)
- Embryos (1)
- Employment (1)
- Ena/VASP proteins (1)
- Endothelium (1)
- Entorhinal cortex lesion (1)
- Environmental enrichment (1)
- Environmental impact (1)
- Enzyme-linked immunoassays (1)
- Epilepsy (1)
- Etanercept (1)
- Europe (1)
- European Society for Immunodeficiencies (ESID) (1)
- Everolimus (1)
- Excitability (1)
- Exercise training (1)
- Exosomes (1)
- Experimental Finance (1)
- Extended donor criteria (1)
- FBS (1)
- FFLU (1)
- FGFR (1)
- Falciparum (1)
- Femoral neck (1)
- Femtoscopy (1)
- Fibre/foam sandwich radiator (1)
- Financial Advice (1)
- Finanzbildung (1)
- Fistula (1)
- Flow cytometry (1)
- Follow-up (1)
- Fondaparinux (1)
- Forschung (1)
- Fracture risk (1)
- Frailty (1)
- Functional outcome (1)
- Functional outcomes (1)
- FungiScope® registry (1)
- GPS collar (1)
- Gene expression (1)
- General practitioners (1)
- Genetic causes of cancer (1)
- Genetic testing (1)
- German PID-NET registry (1)
- Global positioning system (1)
- Guanine nucleotide exchange factors (1)
- Guanosine triphosphatase (1)
- Guidelines (1)
- HADES (1)
- HBT (1)
- HER2-positive (1)
- HNO (1)
- HPV-positive OPSCC (1)
- Hadron production (1)
- Hadron-Hadron Scattering Heavy (1)
- Hadron-hadron interactions (1)
- Hals-Nasen-Ohren-Heilkunde (1)
- Hard Scattering (1)
- Health policy (1)
- Heart (1)
- Heavy Ion Experiment (1)
- Heavy flavor production (1)
- Heavy flavour production (1)
- Heavy ions (1)
- Heavy-Ion Collision (1)
- Heavy-flavour decay muons (1)
- Heavy-flavour production (1)
- Heavy-ion detectors (1)
- Hematologic malignancies (1)
- Hematology (1)
- Hepatocellular carcinoma (1)
- Herafill (1)
- Herbaria (1)
- High-energy neutron detection (1)
- Histology (1)
- Household Finance (1)
- Human behaviour (1)
- Human genetics (1)
- Hypofractionated radiotherapy (1)
- ICU (1)
- IFN-β (1)
- ISS (1)
- IgG substitution therapy (1)
- Immune response (1)
- Immunity (1)
- Immunoassays (1)
- Immunogenetics (1)
- Immunology and Microbiology Section (1)
- Immunomonitoring (1)
- Implantable cardioverter-defibrillator (1)
- Inclusive spectra (1)
- Inflammation (1)
- Intensity interferometry (1)
- Interleukin-17A (1)
- Intra-abdominal infection (1)
- Invariant Mass Distribution (1)
- Invasive candidiasis (1)
- Invasive fungal infections (1)
- Inverse kinematics (1)
- Ionisation energy loss (1)
- Isoproterenol (1)
- Jet Physics (1)
- Jet Substructure (1)
- Jurkat (1)
- K48-linked (1)
- K63-linked (1)
- KDIGO (1)
- KOOS IV (1)
- Kidney (1)
- Knochendefektheilung (1)
- Kupffer cells (1)
- Köcherfliegen (1)
- LASS (1)
- LFP (1)
- Laparostomy (1)
- Large detector systems for particle and astroparticle physics (1)
- Lee-type (1)
- Lehre (1)
- Leukemias (1)
- Library screening (1)
- Lipid signaling (1)
- Literarischer Stil (1)
- Literaturwissenschaft (1)
- Lomentospora prolificans (1)
- Low-molecular-weight heparin (1)
- Luciferase (1)
- Lumbar spine (1)
- Lymphoid Neoplasia (1)
- MACS (1)
- Machine learning (1)
- Macrophages (1)
- Malaria (1)
- Malignancy (1)
- Market Efficiency (1)
- Market efficiency (1)
- Masquelet (1)
- Masquelet technique (1)
- Material budget (1)
- Maternal separation (1)
- Mena/VASP (1)
- Mental health and psychiatry (1)
- Mesh (1)
- Metagenomics (1)
- MicroRNAs (1)
- Mid-rapidity (1)
- Minimum Bias (1)
- Mittelhessen (1)
- Mixed hearing loss (1)
- Models & methods for nuclear reactions (1)
- Molecular neuroscience (1)
- Monitoring (1)
- Monte Carlo (1)
- Motor control (1)
- Mouse models (1)
- Multi-Parton Interactions (1)
- Multi-neutron detection (1)
- Multi-stakeholder approach (1)
- Multi-strange baryons (1)
- Multi-wire proportional drift chamber (1)
- Multimodal imaging (1)
- Multiparametric MRI (1)
- Multiple sclerosis (1)
- Multivariate analysis (1)
- Mutation databases (1)
- Mycoses (1)
- Myocardial infarction (1)
- Myocardial perfusion (1)
- Myocardial segmentation (1)
- NADPH oxidase (1)
- NMR spectroscopy (1)
- NSG mice (1)
- NVBP (1)
- Neoadjuvant therapy (1)
- Neural network (1)
- Neuroinflammation (1)
- Neuroscience (1)
- Neutron physics (1)
- Neutropenia (1)
- Non-small cell lung cancer (1)
- Non-trauma (1)
- Nordhessen (1)
- Nox1 (1)
- NoxO1 (1)
- Nuclear modification factor (1)
- Nuclear resonance fluorescence (1)
- Nuclear structure & decays (1)
- Nucleon induced nuclear reactions (1)
- Nutrition (1)
- ORL (1)
- Observational (1)
- Oldest-old (1)
- Open abdomen (1)
- Organ allocation (1)
- Osteoporosis diagnosis (1)
- Otorhinolaryngology (1)
- Outcome assessment (1)
- Outpatients (1)
- Ovarian cancer (1)
- P2X7 receptor (1)
- PD-1 (1)
- PD-L1 (1)
- PID prevalence (1)
- PKD (1)
- PKD/IC (1)
- PRRT2 (1)
- PSA screening (1)
- PSA-Screening (1)
- PYTHIA (1)
- Pacemaker (1)
- Paediatric research (1)
- Pancreas transplantation (1)
- Pancreatitis (1)
- Pandemic (1)
- Particle and Resonance Production (1)
- Pathological complete response (1)
- Pb–Pb (1)
- Pediatric infections (1)
- Pediatric patients (1)
- Pediatrics (1)
- Performance of High Energy Physics Detectors (1)
- Peritoneal macrophages (1)
- Peritonitis (1)
- Personalized medicine (1)
- Phosphorylation (1)
- Physical activity (1)
- Plasmodium (1)
- Plastic scintillator array (1)
- Pneumonia (1)
- Population-based screening (1)
- Post treatment (1)
- Post-traumatic stress disorder (1)
- Predictive markers (1)
- Prevention (1)
- Preventive medicine (1)
- Production Cross Section (1)
- Prognosis (1)
- Prognostic models (1)
- Properties of Hadrons (1)
- Prostata-specific antigen (1)
- Prostataspezifisches Antigen (1)
- Prostate cancer (1)
- Proteinkinase (1)
- Proton–proton (1)
- Prävention (1)
- Pseudo HE-images (1)
- Psychiatry (1)
- Psychological and psychosocial issues (1)
- Pygmy Dipole Resonance (1)
- Quality of life (1)
- Quark Deconfinement (1)
- Quark Production (1)
- Quark gluon plasma (1)
- Quasi-free scattering (1)
- Quasi-particle phonon model (1)
- Quinine (1)
- REMS (1)
- RNA (1)
- RTS (1)
- Radiative capture (1)
- Radical prostatectomy (1)
- Radiofrequency (1)
- Radiomics (1)
- Raman spectroscopy (1)
- Rapidity Range (1)
- Re-exploration (1)
- Re-injury (1)
- Reactions with relativistic radioactive beams (1)
- Reactive oxygen species (1)
- Real world (1)
- Recall rate (1)
- Recurrence (1)
- Registries (1)
- Rehospitalization (1)
- Reintervention (1)
- Rejection (1)
- Relativistic heavy ion physics (1)
- Relativistic heavy-ion collisions (1)
- Remission (1)
- Renal replacement therapy (1)
- Research (1)
- Research Infrastructure (1)
- Residency (1)
- Resolution Parameter (1)
- Resonance reactions (1)
- Return to play (1)
- Return to sports (1)
- Rhabdomyoma (1)
- Rhabdomyosarcoma (1)
- Rheumatoid arthritis (1)
- Risk assessment (1)
- Ryanodine (1)
- SARS CoV 2 (1)
- SARS-CoV-2 (1)
- SARS-CoV‑2 pandemic (1)
- SARS-CoV‑2-Pandemie (1)
- SMAD (1)
- Saarland (1)
- Scedosporium spp. (1)
- Seasonal variation (1)
- Secondary prevention (1)
- Seizure (1)
- Semantics (1)
- Sensory systems (1)
- Serine proteases (1)
- Severe malaria (1)
- Single muons (1)
- Small molecules (1)
- Solar insolation (1)
- South West Germany (1)
- Specialist training (1)
- Spectrin (1)
- Spectroscopic factors (1)
- Spectroscopic factors & electromagnetic moments (1)
- Stress vulnerability/resilience genes (1)
- Sub-segmentation (1)
- Sunlight (1)
- Superoxide (1)
- Survival analysis (1)
- Sustainable Finance (1)
- Synaptic plasticity (1)
- Synaptopodin (1)
- Synthetic (1)
- Systematic Uncertainty (1)
- T-cell (1)
- TAVI (1)
- TGF-beta (1)
- TGFB-induced factor homeobox 1 (1)
- TGFβ (1)
- TGIF (1)
- TOR1A (1)
- TR (1)
- Taxonomy (1)
- Tea (1)
- Teaching (1)
- Technical data (1)
- Technique (1)
- Textual Analysis (1)
- Textual Sentiment (1)
- Textual analysis (1)
- Textual sentiment (1)
- Therapeutics (1)
- Therapy (1)
- Thoracic trauma (1)
- Time Projection Chamber (1)
- Timing (1)
- Tracking (1)
- Transcriptome analysis (1)
- Transition radiation detector (1)
- Translation (1)
- Transverse momentum (1)
- Trauma (1)
- Trigger (1)
- Triple negative (1)
- Two-hit hypothesis (1)
- Ultrasound (1)
- University hospitals (1)
- Universitätskliniken (1)
- Urinary continence (1)
- Urinary incontinence (1)
- VASP (1)
- VEGF receptor 2 internalization and signaling (1)
- Variant of concern (1)
- Vascular emergencies (1)
- Vector Boson Production (1)
- Venous thrombosis (1)
- Vesicles (1)
- Voriconazole (1)
- Vorsorgeuntersuchung (1)
- Wastewater-based epidemiology (WBE) (1)
- Weiterbildung (1)
- Wide rapidity coverage (1)
- X-ray crystallography (1)
- Xenon-based gas mixture (1)
- Z-inspection (1)
- accessory proteins (1)
- activity sensors (1)
- acute lymphoblastic leukemia (1)
- adenocarcinoma (1)
- alcoholic hepatitis (1)
- allogeneic stem cell transplant (1)
- allogeneic stem cell transplantation (1)
- anaesthesia in orthopaedics (1)
- anaesthetics (1)
- animal personality (1)
- anti-EGFR therapy (1)
- antibiotic resistance (1)
- antibodies (1)
- antifungal combination therapy (1)
- antifungal therapy (1)
- aortic stenosis (1)
- apex (1)
- arachidonate 12/15-lipoxygenase (Alox12/15) (1)
- artifacts (1)
- artificial intelligence (1)
- astrocytes (1)
- atherosclerosis (1)
- attention deficit hyperactivity disorder (1)
- attention-deficit/hyperactivity disorder (ADHD) (1)
- autoantibodies (1)
- b-cell lymphomas (1)
- bacteremia (1)
- behavioural syndrome (1)
- bendamustine (1)
- bioactivity testing (1)
- biodiversity (1)
- biogeographic legaciese (1)
- bloodstream infections (1)
- bone marrow derived mononuclear cells (1)
- bone marrow mononuclear cells (1)
- brain injury (1)
- brown bear (1)
- cAMP (1)
- cGMP (1)
- calcium-independent phospholipase A2β (1)
- calorimeter: electromagnetic (1)
- calretinin (1)
- candidemia (1)
- capture (1)
- cardiac magnetic resonance (1)
- castration resistance (1)
- cell lines (1)
- cell stress (1)
- cell-free protein synthesis (1)
- central nervous system (1)
- ceramide synthase (1)
- ceramides (1)
- cerium (1)
- chemorefractory metastatic colorectal cancer (1)
- chemotherapy (1)
- chemotherapy regimen (1)
- chimeric antigen receptor (CAR) (1)
- chimeric antigen receptor t-cell therapy (1)
- chimeric antigen receptors (1)
- cholestasis (1)
- chronic kidney disease (1)
- chronic total occlusion (1)
- cisplatin (1)
- clinical research (1)
- cohort study (1)
- colon (1)
- combined modality therapy (1)
- component study (1)
- coronary disease (1)
- critical size defect (1)
- cross-section (1)
- cytokine (1)
- dE/dx (1)
- damage detection (1)
- data quality (1)
- decision aids (1)
- delirium (1)
- dementia (1)
- dentate gyrus (1)
- depression (1)
- detector (1)
- diagnostics (1)
- disease prevalence (1)
- disease progression (1)
- double hierarchical model (1)
- double immune checkpoint inhibition (1)
- early recognition (1)
- easyPACId (1)
- ecological and phytosociological classification (1)
- ectosomes (1)
- electroencephalography (EEG) (1)
- electronics: readout (1)
- endocannabinoids (1)
- endothelial cells (1)
- entorhinal cortex lesion (1)
- ethical co-design (1)
- ethics (1)
- excitation transport (1)
- exosomes (1)
- experimental results (1)
- extracellular vesicles (1)
- facial nerve functional outcome (1)
- familial infantile epilepsy (1)
- fatigue testing (1)
- fibre: optical (1)
- fibrosis (1)
- flow cytometry (1)
- fluorine (1)
- fondaparinux (1)
- forest classification (1)
- forest functional similarity (1)
- fragment-based screening (1)
- galactomannan (1)
- gene expression (1)
- genetic phenotypes (1)
- geriatric medicine (1)
- glass fiber reinforced materials (1)
- guidelines (1)
- head and neck neoplasms (1)
- head-and-neck cancer (1)
- healthcare (1)
- hearing nerve (1)
- heavy ion experiments (1)
- hematopoietic cell transplantation (1)
- hemiplegic migraine (1)
- homeostatic synaptic scaling (1)
- human natural killer cell (1)
- human subjects (1)
- hypertension and anti-hypertensive treatment (1)
- imaging (1)
- immune checkpoint blockade (1)
- immune checkpoint inhibitor (ICI) (1)
- immune monitoring (1)
- immune reconstitution (1)
- immunohistochemistry (1)
- impulsivity (1)
- incontinence (1)
- induced membrane (1)
- induction therapy (1)
- infants (1)
- infection (1)
- infections (1)
- inflammasome (1)
- intensive care admission and mortality (1)
- interferon regulatory factor 9 (IRF9) (1)
- interleukin-1β (1)
- interoperability (1)
- intratumoral (1)
- intrinsically disordered region (1)
- invasive mold infection (1)
- layer-specificity (1)
- learning loss (1)
- leukapheresis (1)
- light harvesting networks (1)
- light–energy conversion (1)
- lipids (1)
- lipiodol (1)
- lipoxin A4 (1)
- liver metastasis (1)
- low molecular weight heparin (1)
- low-dose imaging (1)
- lymphoma (1)
- mRNA active cancer immunotherapy (1)
- mTOR (1)
- mTOR inhibitor (1)
- machine learning (1)
- magnetic resonance imaging of the brain (1)
- major depression (1)
- malignant melanoma (1)
- mast cells (1)
- mechanical accuracy (1)
- membranous urethra (1)
- mesenchymal stromal cells (1)
- metabolic syndrome (1)
- metastasis (1)
- metastatic prostate cancer (1)
- microparticles (1)
- microsurgical treatment (1)
- microvesicles (1)
- microwave ablation (1)
- mid-term urinary continence (1)
- mindfulness (1)
- minimal information requirements (1)
- misallocation rate (1)
- misinterpretation rate (1)
- mitral regurgitation (1)
- mitral valve surgery (1)
- mortality (1)
- movement (1)
- multicenter study (1)
- multiparametric magnetic resonance imaging (1)
- multivariate mixed model (1)
- myocardial fibrosis (1)
- n_TOF (1)
- natural products (1)
- neonates (1)
- nerve-sparing surgery (1)
- neurofeedback (1)
- neutron (1)
- neutropenia (1)
- non-ST-segment elevation acute coronary syndrome (1)
- non-neutropenic episode (1)
- nonstructural proteins (1)
- nucleosynthesis (1)
- obesity (1)
- olfaction (1)
- open quantum systems (1)
- optical coherence tomography (1)
- organ preservation (1)
- organotypic slice cultures (1)
- overlooking rate (1)
- p47phox (1)
- pad-test (1)
- patients (1)
- pediatric patients (1)
- penile cancer (1)
- perforant path transection (1)
- perforin (1)
- personality (1)
- phagocytosis (1)
- phantom study (1)
- phenotypic spectrum (1)
- phylogenetic community distance (1)
- pneumonia (1)
- polygenic risk score (1)
- polymerase chain reaction (1)
- polyubiquitin (1)
- preclinical (1)
- primary biliary cholangitis (1)
- primary biliary cirrhosis (1)
- primary immunodeficiency (PID) (1)
- primary sclerosing cholangitis (1)
- proteins (1)
- proteobacteria (1)
- proteomics (1)
- psychotherapy process (1)
- quantum transport (1)
- quark gluon plasma (1)
- radar-based structural health monitoring (1)
- randomized controlled trial (RCT) (1)
- re-exposure (1)
- rechallenge (1)
- registry for primary immunodeficiency (1)
- reintroduction (1)
- repeatability (1)
- reproducibility (1)
- residual intra‐individual variability (1)
- resolution (1)
- resolution of inflammation (1)
- rhabdomyosarcoma (1)
- rigor (1)
- risk assessment (1)
- rituximab (1)
- robot-guided stereotaxy (1)
- s-process (1)
- sarcoma (1)
- scaffold size (1)
- scar (1)
- schizophrenia (1)
- school closure (1)
- second line therapy (1)
- secukinumab (1)
- semiconductors (1)
- simplified production (1)
- single subject classification (1)
- sleep disordered breathing (1)
- smart home (1)
- smart living (1)
- solid tumor (1)
- specialized pro-resolving lipid mediators (SPMs) (1)
- species differences (1)
- spectra (1)
- sprouting angiogenesis (1)
- stability (1)
- standardization (1)
- stereotactic frame (1)
- stereotactic neurosurgery (1)
- stroke (1)
- structural proteins (1)
- student achievement (1)
- survival (1)
- systematic review (1)
- tandem mass spectrometry (1)
- targeted therapy (1)
- telmisartan (1)
- temporal classification (1)
- therapeutic alliance (1)
- tip cell filopodia formation (1)
- toll-like receptor (1)
- tomography (1)
- treatment (1)
- treatment resistance (1)
- treatment response (1)
- tropical forests (1)
- trustworthy AI (1)
- trustworthy AI Co-design (1)
- tumor (1)
- tumor microenvironment (1)
- tumor microenvironment (TME) (1)
- type I interferons (IFNs) (1)
- tyrosine kinase inhibitor (TKI) (1)
- ubiquitin-conjugating enzymes (1)
- urinary incontinence (1)
- ursodeoxycholic acid (1)
- uveal melanoma (1)
- variant of concern (1)
- vascular calcification (1)
- vascular dysfunction and inflammation (1)
- vegetation monitoring (1)
- venous thrombosis (1)
- versican (VCAN) (1)
- vestibular schwannoma (1)
- viral tracing (1)
- virtual reality (1)
- wastewater-based epidemiology (WBE) (1)
- web of things (1)
- weed communities (1)
- wind turbine blades (1)
- Öffentlichkeit (1)
- ß-D-glucan (1)
- γ-ray spectroscopy (1)
- √sN N = 2.76 TeV (1)
Institute
- Physik (1208)
- Frankfurt Institute for Advanced Studies (FIAS) (1040)
- Informatik (1007)
- Medizin (192)
- Geowissenschaften (48)
- Biowissenschaften (9)
- ELEMENTS (8)
- Biochemie, Chemie und Pharmazie (7)
- Georg-Speyer-Haus (6)
- Institut für Ökologie, Evolution und Diversität (6)
This article reports on the inclusive production cross section of several quarkonium states, J/ψ, ψ(2S), Υ(1S), Υ(2S), and Υ(3S), measured with the ALICE detector at the LHC, in \pp collisions at s√=5.02 TeV. The analysis is performed in the dimuon decay channel at forward rapidity (2.5<y<4). The measured cross sections, assuming unpolarized quarkonia, are: σJ/ψ=5.88±0.03±0.34 μb, σψ(2S)=0.87±0.06±0.10 μb, σΥ(1S)=45.5±3.9±3.5 nb, σΥ(2S)=22.4±3.2±2.7 nb, and σΥ(3S)=4.9±2.2±1.0 nb, where the first (second) uncertainty is the statistical (systematic) one. The transverse-momentum (pT) and rapidity (y) differential cross sections for J/ψ, ψ(2S), Υ(1S), and the ψ(2S)-to-J/ψ cross section ratios are presented. For the first time, the cross sections of the three Υ states, as well as the ψ(2S) one as a function of pT and y, are measured at s√=5.02 TeV at forward rapidity. These measurements also significantly extend the J/ψ pT reach with respect to previously published results. A comparison with ALICE measurements in pp collisions at s√=2.76, 7, 8, and 13 TeV is presented and the energy dependence of quarkonium production cross sections is discussed. Finally, the results are compared with the predictions from several production models.
This article reports on the inclusive production cross section of several quarkonium states, J/ψ, ψ(2S), Υ(1S), Υ(2S), and Υ(3S), measured with the ALICE detector at the LHC, in pp collisions at s√=5.02 TeV. The analysis is performed in the dimuon decay channel at forward rapidity (2.5<y<4). The integrated cross sections and transverse-momentum (pT) and rapidity (y) differential cross sections for J/ψ, ψ(2S), Υ(1S), and the ψ(2S)-to-J/ψ cross section ratios are presented. The integrated cross sections, assuming unpolarized quarkonia, are: σJ/ψ(pT<20 GeV/c) = 5.88 ± 0.03 ± 0.34 μb, σψ(2S)(pT<12 GeV/c) = 0.87 ± 0.06 ± 0.10 μb, σΥ(1S)(pT<15 GeV/c) = 45.5 ± 3.9 ± 3.5 nb, σΥ(2S)(pT<15 GeV/c) = 22.4 ± 3.2 ± 2.7 nb, and σΥ(3S)(pT<15 GeV/c) = 4.9 ± 2.2 ± 1.0 nb, where the first (second) uncertainty is the statistical (systematic) one. For the first time, the cross sections of the three Υ states, as well as the ψ(2S) one as a function of pT and y, are measured at s√=5.02 TeV at forward rapidity. These measurements also significantly extend the J/ψ pT reach and supersede previously published results. A comparison with ALICE measurements in pp collisions at s√=2.76, 7, 8, and 13 TeV is presented and the energy dependence of quarkonium production cross sections is discussed. Finally, the results are compared with the predictions from several production models.
This article reports on the inclusive production cross section of several quarkonium states, J/ψ, ψ(2S), Υ(1S), Υ(2S), and Υ(3S), measured with the ALICE detector at the LHC, in pp collisions at s√=5.02 TeV. The analysis is performed in the dimuon decay channel at forward rapidity (2.5<y<4). The integrated cross sections and transverse-momentum (pT) and rapidity (y) differential cross sections for J/ψ, ψ(2S), Υ(1S), and the ψ(2S)-to-J/ψ cross section ratios are presented. The integrated cross sections, assuming unpolarized quarkonia, are: σJ/ψ(pT<20 GeV/c) = 5.88 ± 0.03 ± 0.34 μb, σψ(2S)(pT<12 GeV/c) = 0.87 ± 0.06 ± 0.10 μb, σΥ(1S)(pT<15 GeV/c) = 45.5 ± 3.9 ± 3.5 nb, σΥ(2S)(pT<15 GeV/c) = 22.4 ± 3.2 ± 2.7 nb, and σΥ(3S)(pT<15 GeV/c) = 4.9 ± 2.2 ± 1.0 nb, where the first (second) uncertainty is the statistical (systematic) one. For the first time, the cross sections of the three Υ states, as well as the ψ(2S) one as a function of pT and y, are measured at s√=5.02 TeV at forward rapidity. These measurements also significantly extend the J/ψ pT reach and supersede previously published results. A comparison with ALICE measurements in pp collisions at s√=2.76, 7, 8, and 13 TeV is presented and the energy dependence of quarkonium production cross sections is discussed. Finally, the results are compared with the predictions from several production models.
The very forward energy is a powerful tool for characterising the proton fragmentation in pp and p-Pb collisions and, studied in correlation with particle production at midrapidity, provides direct insightsinto the initial stages and the subsequent evolution of the collision. Furthermore, the correlation between the forward energy and the production of particles with large transverse momenta at midrapidity provides information complementary to the measurements of the underlying event, which are usually interpreted in the framework of models implementing centrality-dependent multiple parton interaction. Results about the very forward energy, measured by the ALICE zero degree calorimeters (ZDC), and its dependence on the activity measured at midrapidity in pp collisions at s√=13 TeV and in p-Pb collisions at sNN−−−√=8.16 TeV are presented and discussed. The measurements performed in pp collisions are compared with the expectations of three hadronic interaction event generators: PYTHIA 6 (Perugia 2011 tune), PYTHIA 8 (Monash tune), and EPOS LHC. These results provide new constraints on the validity of models in describing the beam remnants at very forward rapidities, where perturbative QCD cannot be used.
The very forward energy is a powerful tool for characterising the proton fragmentation in pp and p-Pb collisions and, studied in correlation with particle production at midrapidity, provides direct insightsinto the initial stages and the subsequent evolution of the collision. Furthermore, the correlation between the forward energy and the production of particles with large transverse momenta at midrapidity provides information complementary to the measurements of the underlying event, which are usually interpreted in the framework of models implementing centrality-dependent multiple parton interaction. Results about the very forward energy, measured by the ALICE zero degree calorimeters (ZDC), and its dependence on the activity measured at midrapidity in pp collisions at s√=13 TeV and in p-Pb collisions at sNN−−−√=8.16 TeV are presented and discussed. The measurements performed in pp collisions are compared with the expectations of three hadronic interaction event generators: PYTHIA 6 (Perugia 2011 tune), PYTHIA 8 (Monash tune), and EPOS LHC. These results provide new constraints on the validity of models in describing the beam remnants at very forward rapidities, where perturbative QCD cannot be used.
The jet angularities are a class of jet substructure observables which characterize the angular and momentum distribution of particles within jets. These observables are sensitive to momentum scales ranging from perturbative hard scatterings to nonperturbative fragmentation into final-state hadrons. We report measurements of several infrared- and collinear-safe jet angularities in pp collisions at s√=5.02 TeV with the ALICE detector. Jets are reconstructed using charged particle tracks at midrapidity. The anti-kT algorithm is used with jet resolution parameters R=0.2 and R=0.4 for several transverse momentum pch jetT intervals in the 20−100 GeV/c range. Using the jet grooming algorithm Soft Drop, the sensitivity to softer, wide-angle processes, as well as the underlying event, can be reduced in a way which is well-controlled in theoretical calculations. We report the ungroomed jet angularities, λα, and groomed jet angularities, λα , g, to investigate the interplay between perturbative and nonperturbative effects at low jet momenta. Various angular exponent parameters α=1, 1.5, 2, and 3 are used to systematically vary the sensitivity of the observable to collinear and soft radiation. Results are compared to analytical predictions at next-to-leading-logarithmic accuracy, which provide a generally good description of the data in the perturbative regime but exhibit discrepancies in the nonperturbative regime. Moreover, these measurements serve as a baseline for future ones in heavy-ion collisions by providing new insight into the interplay between perturbative and nonperturbative effects in the angular and momentum substructure of jets. They supply crucial guidance on the selection of jet resolution parameter, jet transverse momentum and angular scaling variable for jet quenching studies.
The jet angularities are a class of jet substructure observables which characterize the angular and momentum distribution of particles within jets. These observables are sensitive to momentum scales ranging from perturbative hard scatterings to nonperturbative fragmentation into final-state hadrons. We report measurements of several groomed and ungroomed jet angularities in pp collisions at s√=5.02 TeV with the ALICE detector. Jets are reconstructed using charged particle tracks at midrapidity (|η|<0.9). The anti-kT algorithm is used with jet resolution parameters R=0.2 and R=0.4 for several transverse momentum pch jetT intervals in the 20−100 GeV/c range. Using the jet grooming algorithm Soft Drop, the sensitivity to softer, wide-angle processes, as well as the underlying event, can be reduced in a way which is well-controlled in theoretical calculations. We report the ungroomed jet angularities, λα, and groomed jet angularities, λα,g, to investigate the interplay between perturbative and nonperturbative effects at low jet momenta. Various angular exponent parameters α=1, 1.5, 2, and 3 are used to systematically vary the sensitivity of the observable to collinear and soft radiation. Results are compared to analytical predictions at next-to-leading-logarithmic accuracy, which provide a generally good description of the data in the perturbative regime but exhibit discrepancies in the nonperturbative regime. Moreover, these measurements serve as a baseline for future ones in heavy-ion collisions by providing new insight into the interplay between perturbative and nonperturbative effects in the angular and momentum substructure of jets. They supply crucial guidance on the selection of jet resolution parameter, jet transverse momentum, and angular scaling variable for jet quenching studies.
The production of prompt D0, D+, and D∗+ mesons was measured at midrapidity (|y|< 0.5) in Pb-Pb collisions at the centre-of-mass energy per nucleon-nucleon pair sNN−−−√ = 5.02 TeV with the ALICE detector at the LHC. The D mesons were reconstructed via their hadronic decay channels and their production yields were measured in central (0-10%) and semicentral (30-50%) collisions. The measurement was performed up to a transverse momentum (pT) of 36 or 50 GeV/c depending on the D meson species and the centrality interval. For the first time in Pb-Pb collisions at the LHC, the yield of D0 mesons was measured down to pT = 0, which allowed a model-independent determination of the pT-integrated yield per unit of rapidity (dN/dy). A maximum suppression by a factor 5 and 2.5 was observed with the nuclear modification factor (RAA) of prompt D mesons at pT = 6-8 GeV/c for the 0-10% and 30-50% centrality classes, respectively. The D-meson RAA is compared with that of charged pions, charged hadrons, and J/ψ mesons as well as with theoretical predictions. The analysis of the agreement between the measured RAA, elliptic (v2) and triangular (v3) flow, and the model predictions allowed us to constrain the charm spatial diffusion coefficient Ds. Furthermore the comparison of RAA and v2 with different implementations of the same models provides an important insight into the role of radiative energy loss as well as charm quark recombination in the hadronisation mechanisms.
he production of prompt D0, D+, and D∗+ mesons was measured at midrapidity (|y|< 0.5) in Pb-Pb collisions at the centre-of-mass energy per nucleon-nucleon pair sNN−−−√ = 5.02 TeV with the ALICE detector at the LHC. The D mesons were reconstructed via their hadronic decay channels and their production yields were measured in central (0-10%) and semicentral (30-50%) collisions. The measurement was performed up to a transverse momentum (pT) of 36 or 50 GeV/c depending on the D meson species and the centrality interval. For the first time in Pb-Pb collisions at the LHC, the yield of D0 mesons was measured down to pT = 0, which allowed a model-independent determination of the pT-integrated yield per unit of rapidity (dN/dy). A maximum suppression by a factor 5 and 2.5 was observed with the nuclear modification factor (RAA) of prompt D mesons at pT = 6-8 GeV/c for the 0-10% and 30-50% centrality classes, respectively. The D-meson RAA is compared with that of charged pions, charged hadrons, and J/ψ mesons as well as with theoretical predictions. The analysis of the agreement between the measured RAA, elliptic (v2) and triangular (v3) flow, and the model predictions allowed us to constrain the charm spatial diffusion coefficient Ds. Furthermore the comparison of RAA and v2 with different implementations of the same models provides an important insight into the role of radiative energy loss as well as charm quark recombination in the hadronisation mechanisms.
We report on the inclusive J/ψ production cross section measured at the CERN Large Hadron Collider in proton-proton collisions at a centre-of-mass energy s√ = 13 TeV. The J/ψ mesons are reconstructed in the e+e− decay channel and the measurements are performed at midrapidity (|y|<0.9) in the transverse-momentum interval 0<pT<40 GeV/c, using a minimum bias data sample corresponding to an integrated luminosity Lint=32.2 nb−1 and an Electromagnetic Calorimeter triggered data sample with Lint=8.3 pb−1. The pT-integrated J/ψ production cross section at midrapidity, computed using the minimum bias data sample, is dσ/dy|y=0=8.97±0.24 (stat)±0.48 (syst)±0.15 (lumi) μb. An approximate logarithmic dependence with the collision energy is suggested by these results and available world data, in agreement with model predictions. The integrated and pT-differential measurements are compared with measurements in pp collisions at lower energies and with several recent phenomenological calculations based on the non-relativistic QCD and Color Evaporation models.